dynalabs.us - Announcements

Announcements - DYNALABS

Dynalabs.us Spined HTML

Announcements - DYNALABS 888.396.2522 314.241.3962 888.396.2522   •   314.241.3962   •   info@dynalabs.us LOGIN User Registration Account Registration  Menu Close Login User Registration Account Registration Products & Services Lab Services State-of-the-art tampering testing laboratory provides data you need to run your business. On Site Testing Less than 4 seconds to objectively verify drug identity and strength in your facility. CQI Program Use our expert knowledge of the pharmaceutical industry to help you grow your business. Continuous Quality Improvement (CQI) Consulting Services Customer Improvement System Customer Production System Data Analytics Laboratory Services Test Services Lab Services API (Active Pharmaceutical Ingredient ) list DVx™ On site Drug Verification DVx™ Specifications DVx™ Validation Process DVx™ General FAQs On-site Managed Services Consulting Improvement Systems Production System Six Step Approach DYNALABS OOS Process Online Services Sample Submission Customer Service What We DoHospital Pharmacies Stability of Drug Diversion of Drug In House Training Product Validation Drug Investigation Compounding Pharmacies People: Training Validation Program Materials: Vendor Qualification Program Equipment: Performance Validation Program Process: Process Validation Program Product: Product Validation Program Frequently Asked Questions CompanyOur Story Announcements Announcing a new NationalFinanceManager, Christine Versichele. DYNALABS announces new Chief Technology Officer DYNALABS welcomes a new Principal Consultant DYNALABS embarks on $1.2 million expansion DYNALABS Announces a New Vice President of Sales DYNALABS announces Director of Quality & Regulatory Affairs DYNALABS LLC Named One of Inc. 5000 Fastest-Growing Private Companies in 2017 DYNALABS named to the 50 Fastest Growing Companies of 2017 DYNALABS Enhances Antimicrobial Effectiveness Testing for USP Potency Testing for Oxytocin DYNALABS Announces New President DYNALABS investment doubles the size of its testing facility Custom Packing Slip DYNALABS Receives ISO/IEC 17025WarrantEntrepreneurial Success SmallMerchantryof the Year 2016 DYNALABS investment doubles the size of its testing facility Enforcing FDA Labeling Policies Entrepreneurial SuccessRibbonEvents Registrations and Awards Vision, Mission Leadership Partners and Alliances Investor Information ResourcesWebinars Blogs Industry News FDA to Remove APIs from list FDA Drug Shortages The Pharma Reports The Pharma Report | Sept 2018 Tech Bulletin | June 2018 Tech Bulletin | May 2018 Tech Bulletin | April 2018 Tech Bulletin | March 2018 Tech Bulletin | February 2018 Tech Bulletin | January 2018 Tech Bulletin | December 2017 Careers Contact < Home | Company | Announcements Announcements “Maximizing the full potential of others” DYNALABS’ own Nichole DiLoretta was nominated to be one of the Wonder Women for St. Louis SmallMerchantrymonthly. We very proud of her and her devotion to us here ate DYNALABS but to the people she helps outside the work place. Nice Work Nicole! READ THE ARTICLE> Announcing a new NationalFinanceManager, Christine Versichele. In this role, Christine’s focus will be working directly with strategic multi-national and global finance within the pharmaceutical compounding industry. This focus is resulting with DYNALABS’ merchantry model for sustainable velocious growth. We believe Christine’s vast industry knowledge and wits will serve her well in identifying new opportunities and developing cost-effective custom solutions. As National Account Manager, Christine will remoter promote DYNALABS’ guiding principles – Patient Safety, Affordable Healthcare, andMerchantrySuccess – within the market place. READ MORE > Announcing a new NationalFinanceManager, Christine Versichele. In this role, Christine’s focus will be working directly with strategic multi-national and global finance within the pharmaceutical compounding industry. This focus is resulting with DYNALABS’ merchantry model for sustainable velocious growth. We believe Christine’s vast industry knowledge and wits will serve her well in identifying new opportunities and developing cost-effective custom solutions. As National Account Manager, Christine will remoter promote DYNALABS’ guiding principles – Patient Safety, Affordable Healthcare, andMerchantrySuccess – within the market place. READ MORE >   DYNALABS is pleased to signify Tim Johnson as Chief Technology Officer. Tim has wide-stretching technology, executive, and start-up wits in the health care, public, and technology sector. Tim will use that wits to help DYNALABS maintain our competitive wholesomeness as technology leaders in our current and future market space. READ MORE > DYNALABS is pleased to signify Kristopher Le as our new Principal Consultant. In this role, Kris will provide greater focus on DYNALABS’ Consulting Practice with the goal of strengthening our current service offerings. Kris joins DYNALABS with a wealth of wits and knowledge. He has held various roles in our industry, including licensed pharmacist and the Director of 503B Operations. Kris has wits in sterile and non-sterile compounding, developing SOPs and formulas as related to the compounding of sterile and non-sterile products, ensuring pharmacy compliance of state regulations and laws as well as USP <795> and USP <797> guidelines, profitable in the minutiae of equipment/process validation programs, performing GAP analysis/audits to ensure cGMP and/or USP <797> compliance, initiation and maintenance of quality systems, and many other duties. READ MORE > DYNALABS embarks on $1.2 million expansion DYNALABS LLC, a St. Louis-based pharmaceuticals testing lab, is spending $1.2 million to expand its microbiology lab and office space, the visitor said. The renovation, expected to be well-constructed in the first quarter of 2018, will double topics to relieve overcrowding and modernize workflow, among other changes, officials said. READ MORE > Link toMerchantryJournal Ad > DYNALABS announces Director of Quality & Regulatory Affairs DYNALABS LLC is pleased to signify Nichole DiLorretta as our Director of Quality & Regulatory Affairs. Nichole is responsible for daily QA operations as well as corporate projects related to quality and regulatory compliance. Nichole holds a Bachelor of Science in Biology, with an accent in Biochemistry from Southern Illinois University. She holds Forensic Science and Forensic Chemistry and Analysis certification from Saint Louis University. READ MORE >  DYNALABS LLC Named One of Inc. 5000 Fastest-Growing Private Companies in 2017 ST. LOUIS – For the fourth time, DYNALABS LLC made the 2017 Inc. 5000 list of the fastest-growing private companies in America. Out of nearly 7 million private companies moving the economy forward every day, only a small fraction demonstrate remarkable and resulting upper growth. DYNALABS LLC is proud to have made this list again. DYNALABS continues to grow every day and impacts the economy and patients’ safety and lives.  It conducts all merchantry with its guiding principles of patient safety, affordable healthcare, and merchantry success on our mind. READ MORE > DYNALABS Announces a New Vice President of Sales DYNALABS is pleased to signify Bill Russell as our new Vice President of Sales to remoter develop and grow our merchantry while pursuit our Guiding Principles: Patient Safety Affordable HealthcareMerchantrySuccess Bill Russell brings a wealth of wits to DYNALABS.  With over 20 years of sales and marketing experience, Bill has ripened and driven sales in diverse merchantry industries.  He has directed key initiatives, unchangingly ensuring structuring and collaboration among sales, technical, and operations staff to maximize sales results. READ MORE > DYNALABS offers Low Concentration Oxytocin potency by UltraUpperPerformance Liquid Chromatography (UHPLC) New Potency Testing Capability –  DYNALABS has transitioned from Liquid Chromatography/Mass Spectrometry for quantitation of Low Concentration Oxytocin and now has a stability indicating method of testing Low Concentration Oxytocin using UltraUpperPerformance Liquid Chromatography as low as 15mU/mL. The new method is increasingly efficient method and provides increasingly well-judged results than LC/MS due to the reproducibility of the instrumentation which reduces the likelihood of system suitability issues. READ MORE > DYNALABS Announces New President We’re pleased to signify that Jun Fabella has wonted the position of President of DYNALABS. For some time now, Jun has been leading the momentum to expand our infrastructure with the goal of enhancing our efficiencies and processes. In doing so, he has been executing the DYNALABS’ philosophy of ‘relentless pursuit of excellence’. READ MORE > DYNALABS Enhances Antimicrobial Effectiveness Testing for USP <51> Through the standing enhancement of our internal systems and sample receipt processes, the testing for USP <51> has seen a significant reduction of time in receiving these test results. Antimicrobial Effectiveness testing is performed to determine the efficacy of preservatives within a recipe versus specific rencontre organisms. DYNALABS’ AE testing procedure is based of USP installment 51 guidelines. This test is used for testing multi-dose pharmaceuticals and products. Testing for USP<51> requires Suitability Testing and will moreover require the preservative to be supposed on the samples labeling. Required sample amount(s) for the the routine testing will be based upon the preservative indicated. Continue Reading > Custom Packing Slip Improvements to our Test Request process The DYNALABS’ online Test Request process will soon generate automatically a custom packing slip. You enter no spare data; the information needed for the packing slip has once been entered as part of the normal sample submission web pages; all you do is click on the ‘Submit and Print” button. The packing slip includes your vendee information, as well as all the information needed well-nigh the lots stuff submitted to DYNALABS. Benefits of the new packing slip include the worthiness to receive your shipments increasingly efficiently and quickly, and to process the requested tests increasingly precisely. Continue Reading > DYNALABS Receives ISO/IEC 17025WarrantSt. Louis, Missouri – DYNALABS is pleased to signify that the American Association for LaboratoryWarrant(A2LA) has tried our visitor for ISO/IEC 17025 accreditation. To proceeds the accreditation, DYNALABS underwent a thorough towage of its quality management processes, and competency to perform tampering and microbiological testing on pharmaceutical raw materials and compounded drug products. READ THE RELEASE >  DYNALABS LLC and a large North American hospital have signed an try-on to test their DVx™ versus drug diversion. Drug diversion, theft and unapproved usage of narcotic drugs, is a worldwide problem in health superintendency today. Since the DVx-04™ can identify such drugs, and moreover snift if they have been manipulated, the DVx-04 could be used as a possible tool to prevent this development. The interest in using the  DVx-04™ for this purpose has been strengthened in the recent past. After a period of negotiation, Dynalabs LLC has now signed an try-on with a large North American hospital for an evaluation of the DVx-04™ versus drug diversion. The system will be installed very soon and the evaluation is expected to last up to 3 months. 2015 SALUTE TO BUSINESS ACHIEVEMENT AWARDS Russell Odegard, MBA 2002 Entrepreneurial Spirit Russell Odegard graduated in 2002 with a MBA and has a BSc with specialization in Microbiology from the University of Alberta, Canada. Russell is the co-founder and managing partner of DYNALABS LLC, an internationally recognized contract laboratory and quality warranty service supplier to the hospital, pharmacy, and pharmaceutical marketplaces. Russell possesses over 30 years of wits that spans vital cancer research, product development, and operations and quality management in the medical diagnostic, life sciences and pharmacy industries. Over the undertow of his career, Russell has held executive-level positions in small start-ups as well as large corporations, and successfully launched two companies, coordinated the minutiae and commercialization of over 700 products worldwide, and received two patents. Russell, his merchantry partner Michael Pruett, and their wives Lina Odegard and Leslie Compton-Pruett fund student scholarships at the St. Louis College of Pharmacy and at the University of Missouri-St. Louis. Russell serves on the Financial Advisory Board at UMSL, the MOBIO Board of Directors, and enjoys guest speaking at local colleges whenever he gets the chance. In his spare time, Russell enjoys spending time with his children and grandchildren, exercising, riding motorcycles, and traveling with his wife Lina. Read The UMSL Article >>> Mayor Francis G. Slay delivers the Spirit of St. LouisRibbonto DYNALABS DYNALABS received the Spirit of St. LouisRibbonpresented by the Mayor of St. Louis, Mayor Francis G. Slay. This ribbon was given in recognition of DYNALABS stuff one of the fastest growing merchantry in the nation and showing remarkable innovations in the pharmaceutical industry. The demand and growth for tampering testing and consulting services from DYNALABS unliable the visitor to move from the incubator into it’s own headquarters at Chouteau Crossing. House Majority Leader Eric Cantor Visits DYNALABS ST. LOUIS, April 13, 2012 — House Majority leader Eric Cantor was in St. Louis this week to speak at the National Rifle Association (NRA) national conference. In wing to this event, he moreover wanted to have the opportunity to meet with an up and coming small merchantry in St. Louis. A visitor that would represent the new “growth engine” for the American economy. DYNALABS LLC is registered with the U.S. Food and Drug Administration (FDA), DEA and Bureau of Narcotics and Dangerous Drugs licensed, as well as ISO 17025 accredited. The products and services provided by DYNALABS are protected by U.S. Patent Nos. 7,197,405 and 7,660,678. © 2018 DYNALABS LLC. All Rights Reserved. For spare information well-nigh DYNALABS please undeniability 888-396-2522   •   info@dynalabs.usTerms Of Use   •   Privacy Policy   •   CustomerTry-on